Unknown

Dataset Information

0

A functional approach reveals a genetic and physical interaction between ribonucleotide reductase and CHK1 in mammalian cells.

ABSTRACT: Ribonucleotide reductase (RNR) enzyme is composed of the homodimeric RRM1 and RRM2 subunits, which together form a heterotetramic active enzyme that catalyzes the de novo reduction of ribonucleotides to generate deoxyribonucleotides (dNTPs), which are required for DNA replication and DNA repair processes. In this study, we show that ablation of RRM1 and RRM2 by siRNA induces G1/S phase arrest, phosphorylation of Chk1 on Ser345 and phosphorylation of ?-H2AX on S139. Combinatorial ablation of RRM1 or RRM2 and Chk1 causes a dramatic accumulation of ?-H2AX, a marker of double-strand DNA breaks, suggesting that activation of Chk1 in this context is essential for suppression of DNA damage. Significantly, we demonstrate for the first time that Chk1 and RNR subunits co-immunoprecipitate from native cell extracts. These functional genomic studies suggest that RNR is a critical mediator of replication checkpoint activation.

SUBMITTER: Taricani L 

PROVIDER: S-EPMC4222937 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

A functional approach reveals a genetic and physical interaction between ribonucleotide reductase and CHK1 in mammalian cells.

Taricani Lorena L   Shanahan Frances F   Malinao Maria-Christina MC   Beaumont Maribel M   Parry David D  

PloS one 20141106 11

Ribonucleotide reductase (RNR) enzyme is composed of the homodimeric RRM1 and RRM2 subunits, which together form a heterotetramic active enzyme that catalyzes the de novo reduction of ribonucleotides to generate deoxyribonucleotides (dNTPs), which are required for DNA replication and DNA repair processes. In this study, we show that ablation of RRM1 and RRM2 by siRNA induces G1/S phase arrest, phosphorylation of Chk1 on Ser345 and phosphorylation of γ-H2AX on S139. Combinatorial ablation of RRM1  ...[more]

Similar Datasets

Unknown MEK2 regulates ribonucleotide reductase activity through functional interaction with ribonucleotide reductase small subunit p53R2.
| S-EPMC3466523 | biostudies-literature
Unknown Physical interaction between human ribonucleotide reductase large subunit and thioredoxin increases colorectal cancer malignancy.
| S-EPMC5454097 | biostudies-literature
Unknown Inhibition of CHK1 sensitizes Ewing sarcoma cells to the ribonucleotide reductase inhibitor gemcitabine.
| S-EPMC5675612 | biostudies-literature
Other The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity
2024-04-04 | GSE263176 | GEO
Unknown Iron Chelator Transmetalative Approach to Inhibit Human Ribonucleotide Reductase.
| S-EPMC8243325 | biostudies-literature
Unknown Assembly of a fragmented ribonucleotide reductase by protein interaction domains derived from a mobile genetic element.
| S-EPMC3045599 | biostudies-literature
Unknown Regulation of mammalian ribonucleotide reductase R1 mRNA stability is mediated by a ribonucleotide reductase R1 mRNA 3'-untranslated region cis-trans interaction through a protein kinase C-controlled pathway.
| S-EPMC1137199 | biostudies-other
Unknown Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer.
| S-EPMC3680937 | biostudies-literature
Unknown A mammalian functional-genetic approach to characterizing cancer therapeutics.
| S-EPMC3070540 | biostudies-literature
Unknown Physical and genetic-interaction density reveals functional organization and informs significance cutoffs in genome-wide screens.
| S-EPMC3645594 | biostudies-literature